These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8191408)

  • 1. Experimental carotid thrombosis in the guinea pig.
    Roux S; Carteaux JP; Hess P; Falivene L; Clozel JP
    Thromb Haemost; 1994 Feb; 71(2):252-6. PubMed ID: 8191408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
    Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of early reocclusion after thrombolysis of copper coil-induced thrombi in the canine carotid artery: comparison of PEG-hirudin and unfractionated heparin.
    Rübsamen K; Hornberger W
    Thromb Haemost; 1996 Jul; 76(1):105-10. PubMed ID: 8819261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonpeptide factor Xa inhibitors III: effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbits.
    Wong PC; Crain EJ; Watson CA; Zaspel AM; Wright MR; Lam PY; Pinto DJ; Wexler RR; Knabb RM
    J Pharmacol Exp Ther; 2002 Dec; 303(3):993-1000. PubMed ID: 12438519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of middle cerebral artery thrombosis by novel glycoprotein IIb/IIIa antagonist FK419 in guinea pig.
    Moriguchi A; Mihara K; Aoki T; Maeda M; Tojo N; Matsuoka N; Mutoh S
    Eur J Pharmacol; 2004 Sep; 498(1-3):179-88. PubMed ID: 15363993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of arterial thrombus formation in two canine models: comparison of ancrod, a fibrinogen-depleting agent, the thrombin-inhibitor r-hirudin, and the glycoprotein 11b/IIIa-receptor antagonist Ro 43-8857.
    Rübsamen K; Hornberger W; Kirchengast M
    Thromb Haemost; 1995 Nov; 74(5):1353-60. PubMed ID: 8607122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A technique to investigate microvascular mural thrombus formation in arteries and veins: II. Effects of aspirin, heparin, r-hirudin, and G-4120.
    Stockmans F; Stassen JM; Vermylen J; Hoylaerts MF; Nyström A
    Ann Plast Surg; 1997 Jan; 38(1):63-8. PubMed ID: 9015542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated clotting time as an appropriate test to compare heparin and direct thrombin inhibitors such as hirudin or Ro 46-6240 in experimental arterial thrombosis.
    Carteaux JP; Gast A; Tschopp TB; Roux S
    Circulation; 1995 Mar; 91(5):1568-74. PubMed ID: 7867200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonpeptide factor Xa inhibitors II. Antithrombotic evaluation in a rabbit model of electrically induced carotid artery thrombosis.
    Wong PC; Crain EJ; Knabb RM; Meade RP; Quan ML; Watson CA; Wexler RR; Wright MR; Slee AM
    J Pharmacol Exp Ther; 2000 Oct; 295(1):212-8. PubMed ID: 10991981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FK419, a novel nonpeptide GPIIb/IIIa antagonist, restores microvascular patency and improves outcome in the guinea-pig middle cerebral artery thrombotic occlusion model: comparison with tirofiban.
    Moriguchi A; Maeda M; Mihara K; Aoki T; Matsuoka N; Mutoh S
    J Cereb Blood Flow Metab; 2005 Jan; 25(1):75-86. PubMed ID: 15678114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of experimental carotid artery thrombosis by applaggin.
    Rote WE; Mu DX; Roncinske RA; Frelinger AL; Lucchesi BR
    J Pharmacol Exp Ther; 1993 Nov; 267(2):809-14. PubMed ID: 8246155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of arterial thrombosis by intravenously administered platelet P2T receptor antagonist AR-C69931MX in a canine model.
    Huang J; Driscoll EM; Gonzales ML; Park AM; Lucchesi BR
    J Pharmacol Exp Ther; 2000 Nov; 295(2):492-9. PubMed ID: 11046080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced effect of aspirin on thrombus formation at high shear and disturbed laminar blood flow.
    Barstad RM; Orvim U; Hamers MJ; Tjønnfjord GE; Brosstad FR; Sakariassen KS
    Thromb Haemost; 1996 May; 75(5):827-32. PubMed ID: 8725731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of napsagatran (Ro 46-6240), a new synthetic thrombin inhibitor and of heparin in a canine model of coronary artery thrombosis: comparison with an ex vivo annular perfusion chamber model.
    Roux S; Tschopp T; Baumgartner HR
    J Pharmacol Exp Ther; 1996 Apr; 277(1):71-8. PubMed ID: 8613969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis.
    Golino P; Ragni M; Cirillo P; D'Andrea D; Scognamiglio A; Ravera A; Buono C; Ezban M; Corcione N; Vigorito F; Condorelli M; Chiariello M
    Circ Res; 1998 Jan 9-23; 82(1):39-46. PubMed ID: 9440703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of antithrombotic effect and bleeding time prolongation in rabbits by inhibiting tissue factor function.
    Himber J; Kirchhofer D; Riederer M; Tschopp TB; Steiner B; Roux SP
    Thromb Haemost; 1997 Sep; 78(3):1142-9. PubMed ID: 9308768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of thrombin active site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleeding.
    Schumacher WA; Steinbacher TE; Heran CL; Seiler SM; Michel IM; Ogletree ML
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1237-42. PubMed ID: 8263785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of the therapeutic index of marketed anti-coagulants and anti-platelet agents by guinea pig models of thrombosis and hemostasis.
    Bird JE; Giancarli MR; Allegretto N; Barbera F; Wong P; Schumacher WA; Ogletree ML; Seiffert D
    Thromb Res; 2008; 123(1):146-58. PubMed ID: 18479740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a synthetic peptide corresponding to residues 313 to 320 of the alphaIIb subunit of the human platelet integrin alphaIIbbeta3 on carotid artery thrombosis in rabbits.
    Papamichael ND; Stathopoulou EM; Roussa VD; Tsironis LD; Kotsia AP; Stanica RM; Moussis V; Tsikaris V; Katsouras CS; Tselepis AD; Michalis LK
    J Pharmacol Exp Ther; 2009 May; 329(2):634-40. PubMed ID: 19244095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.